Ashraf Harahsheh, M.D., F.A.C.C., F.A.A.P.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Dr. Harahsheh serves as a scientific advisory board member of OP2 DRUGS (“OP2”).
    Topic: 
    Kawasaki
    Date added: 
    06/23/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    11/30/2024
    Date reviewed: 
    04/10/2024
Return to 2024 Children's National Heart Institute Critical Event Review 04/29/2024